ストックスクリーナーアプリを入手
34.50
1.32%
0.45
アフターアワーズ：
34.50
前日終値:
$34.05
開ける：
$34.05
24時間の取引高:
531.75K
Relative Volume:
0.77
時価総額：
$1.98B
収益：
$681.88M
当期純損益:
$122.63M
株価収益率:
16.35
EPS:
2.11
ネットキャッシュフロー:
$220.18M
1週間 パフォーマンス:
+0.97%
1か月 パフォーマンス:
+17.19%
6か月 パフォーマンス:
-0.49%
1年 パフォーマンス:
+19.50%
1日の値動き範囲:
$33.66
$34.61
1週間の範囲:
$33.47
$35.34
52週間の値動き範囲:
$26.47
$41.61
Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile
名前
Harmony Biosciences Holdings Inc
セクター
電話
(484) 539-9800
住所
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
HRMY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
34.50 | 1.96B | 681.88M | 122.63M | 220.18M | 2.11 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-11 | 開始されました | Deutsche Bank | Buy |
| 2024-12-17 | 開始されました | H.C. Wainwright | Buy |
| 2024-10-10 | 再開されました | Raymond James | Outperform |
| 2024-09-10 | 開始されました | UBS | Buy |
| 2024-06-21 | 開始されました | Citigroup | Buy |
| 2024-01-02 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-09-25 | ダウングレード | Goldman | Neutral → Sell |
| 2023-09-07 | 開始されました | Berenberg | Buy |
| 2023-04-20 | 開始されました | BofA Securities | Neutral |
| 2022-10-14 | アップグレード | Janney | Neutral → Buy |
| 2022-10-14 | アップグレード | Jefferies | Hold → Buy |
| 2022-08-03 | ダウングレード | Jefferies | Buy → Hold |
| 2022-07-13 | ダウングレード | Goldman | Buy → Neutral |
| 2022-07-07 | 開始されました | Mizuho | Buy |
| 2022-04-14 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-12-01 | 開始されました | Oppenheimer | Outperform |
| 2021-11-04 | 開始されました | Raymond James | Outperform |
| 2021-09-23 | 開始されました | Needham | Buy |
| 2021-03-29 | アップグレード | Goldman | Neutral → Buy |
| 2020-09-14 | 開始されました | Goldman | Neutral |
| 2020-09-14 | 開始されました | Jefferies | Buy |
| 2020-09-14 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Harmony Biosciences Holdings Inc (HRMY) 最新ニュース
Nuveen Asset Management LLC Buys 8,193 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Bank of America Corp DE Decreases Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Ameriprise Financial Inc. Purchases 18,730 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Recommendation of “Buy” by Analysts - Defense World
When (HRMY) Moves Investors should Listen - news.stocktradersdaily.com
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Bought by Deutsche Bank AG - Defense World
A Piece Of The Puzzle Missing From Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) 26% Share Price Climb - simplywall.st
BNP Paribas Financial Markets Invests $2.03 Million in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences (NASDAQ:HRMY) Price Target Raised to $48.00 - Defense World
The Manufacturers Life Insurance Company Acquires 2,144 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock Position Increased by Northern Trust Corp - Defense World
Comerica Bank Acquires 2,919 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences (NASDAQ:HRMY) Upgraded at Cantor Fitzgerald - Defense World
Harmony Biosciences (HRMY): Mizuho Raises Price Target to $48 | - GuruFocus
Harmony Biosciences (HRMY): Mizuho Raises Price Target to $48 | HRMY Stock News - GuruFocus
Mizuho raises Harmony Biosciences stock target to $48 - Investing.com
Harmony Biosciences (HRMY) Sees Price Target Increase Following Positive Q1 Results | HRMY Stock News - GuruFocus
Mizuho raises Harmony Biosciences stock target to $48 By Investing.com - Investing.com India
Mizuho Raises Price Target on Harmony Biosciences to $48 From $44, Keeps Outperform Rating - marketscreener.com
Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $48 at Mizuho - StreetInsider
HARMONY BIOSCIENCES REITERATES CONFIDENCE IN WAKIX® (PITOLISANT) PATENTS FOLLOWING FAVORABLE DECISION BY U.S. PATENT AND TRADEMARK OFFICE (USPTO) TO DENY PETITION FOR REEXAMINATION - Seeking Alpha
Why Harmony Biosciences Holdings' (NASDAQ:HRMY) Earnings Are Better Than They Seem - simplywall.st
We Like Harmony Biosciences Holdings' (NASDAQ:HRMY) Earnings For More Than Just Statutory Profit - Yahoo Finance
Where are the Opportunities in (HRMY) - news.stocktradersdaily.com
Top 5 US Stocks To Buy In May 2025 - Investing.com
Investors who lost money on Harmony Biosciences Holdings, Inc. should contact Levi & Korsinsky about an ongoing investigationHRMY - ACCESS Newswire
Results: Harmony Biosciences Holdings, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - simplywall.st
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2025 Earnings Call Transcript - Insider Monkey
Harmony Biosciences Holdings First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Harmony Biosciences (HRMY) Maintains "Buy" Rating with $49 Price Target | HRMY Stock News - GuruFocus
Harmony Biosciences Holdings Inc (HRMY) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... - Yahoo Finance
Harmony Biosciences Holdings Inc (HRMY) Q1 2025 Earnings Call Hi - GuruFocus
Decoding Harmony Biosciences Holdings Inc (HRMY): A Strategic SW - GuruFocus
Harmony Biosciences Reports Strong Q1 2025 Results - TipRanks
Harmony Biosciences Reports Strong Earnings and Growth - TipRanks
Harmony Biosciences Holdings, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:HRMY) - Seeking Alpha
Harmony Biosciences reports Q1 EPS $1.03, consensus 91c - TipRanks
Harmony Biosciences Q1 2025 Earnings Call Transcript - MarketBeat
Harmony (HRMY) Reports Increase in Cash and Investments | HRMY S - GuruFocus
Harmony Biosciences (HRMY) Receives Buy Rating Reiteration by Ne - GuruFocus
Harmony Biosciences Q1 Adjusted Earnings, Revenue Increase; 2025 Sales Outlook Reiterated - marketscreener.com
Deep Dive Into Harmony Biosciences Hldgs Stock: Analyst Perspectives (13 Ratings) - Benzinga
Harmony Biosciences (HRMY) Receives Buy Rating Reiteration by Needham | HRMY Stock News - GuruFocus
Harmony Biosciences Holdings, Inc. (HRMY) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
Harmony Biosciences Q1 2025 Earnings: EPS of $0.78 and Revenue o - GuruFocus
Harmony Biosciences Holdings, Inc. SEC 10-Q Report - TradingView
Harmony Biosciences (HRMY) Reports Q1 Revenue Surpassing Expecta - GuruFocus
Harmony Biosciences Reports Strong Q1 2025 Financial Results, Highlights Advancement of Its Pipeline and Upcoming Catalysts, and Reaffirms 2025 Revenue Guidance ? | HRMY Stock News - GuruFocus
Harmony (HRMY) Reports Increase in Cash and Investments | HRMY Stock News - GuruFocus
Harmony Biosciences (HRMY) Reports Q1 Revenue Surpassing Expectations | HRMY Stock News - GuruFocus
Harmony Biosciences Holdings Inc (HRMY) 財務データ
収益
当期純利益
現金流量
EPS
1.89%
3.74%
大文字化:
|
ボリューム (24 時間):